| Literature DB >> 26828792 |
Linlin Fan1, Hongji Li1, Yongwu Niu1, Qihe Chen1,2.
Abstract
Mannosylerythritol lipids (MELs) are natural glycolipid biosurfactants which have potential applications in the fields of food, cosmetic and medicine. In this study, MELs were produced from vegetable oil by Pseudozyma aphidis. Their structural data through LC/MS, GC/MS and NMR analysis revealed that MEL-A with two acetyls was the major compound and the identified homologs of MEL-A contained a length of C8 to C14 fatty acid chains. This glycolipid exhibited a surface tension of 27.69 mN/m at a critical micelle concentration (CMC), self-assembling into particles in the water solution. It was observed to induce cell growth-inhibition and apoptosis of B16 melanoma cells in a dose-dependent manner, as well as cause cell cycle arrest at the S phase. Further quantitative RT-PCR analysis and western blotting revealed an increasing tendency of both mRNA and protein expressions of Caspase-12, CHOP, GRP78 and Caspase-3, and a down-regulation of protein Bcl-2. Combined with the up regulation of signaling IRE1 and ATF6, it can be speculated that MEL-A-induced B16 melanoma cell apoptosis was associated with the endoplasmic reticulum stress (ERS).Entities:
Mesh:
Substances:
Year: 2016 PMID: 26828792 PMCID: PMC4734834 DOI: 10.1371/journal.pone.0148198
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 7Effects of MEL-A on the protein expression and mRNA expression in B16 cells.
(A) and (B), protein expression analysis of Caspase-3, cleaved Caspase-3, Caspase-12, Bcl-2, CHOP and GRP78 in the B16 cells treated with 15.0 μg/mL MEL-A for 24 h. The untreated cells were used as control. (C) and (D), fold changes of IRE1 and ATF6 protein expression. (E), mRNA expression analysis of Bcl-2, Caspase-3, CHOP, GRP78 and Caspase-12 in the B16 cells treated with 15.0 μg/mL MEL-A for 24 h. The untreated cells were used as control. Mean ± SD, n = 3.
Fig 4The viabilities of B16 cells and NIH3T3 cells in response to MEL-A treatments.
(a), B16 cells treated with increasing doses of MEL-A had obvious changes. (b), the viability of the normal NIH3T3 cells treated by 15.0 μg/mL MEL-A for 72 h. (c, d, e, f) refers to the photographs of untreated B16 cells, and cells treated with MEL-A for 24 h, 48 h and 72 h. (g, h, m, n) refers to the photographs of untreated NIH3T3 cells and cells treated with MEL-A for 24 h, 48 h, and 72 h, respectively.
Detected MEL-A homologs with various masses and fatty acids chain combinations.
| NO. | [M+Na]+ | [M+NH4]+ | [M+NH4-C4H10O4]+ | Molecular mass | Structure of fatty acids | Relative quantity (%) |
|---|---|---|---|---|---|---|
| M1 | 642.9 | 637.9 | 498.8 | 619.9 | C8:0-C8:0 | 2.15 |
| M2 | 666.9 | 661.9 | 522.9 | 643.9 | C8:0-C10:2 | 6.43 |
| M3 | 669.9 | 663.9 | 524.9 | 645.9 | C8:0-C10:1 or C8:1-C10:0 | 22.89 |
| M4 | 670.9 | 665.9 | 526.9 | 647.9 | C8:0-C10:0 | 9.81 |
| M5 | 695.0 | 690.0 | 550.7 | 672.0 | C8:0-C12:2 | 19.2 |
| M6 | 698.9 | 693.9 | 550.8 | 675.9 | C8:0-C12:0 | 2.99 |
| M7 | 696.7 | 691.7 | 552.9 | 673.7 | C10:0-C10:1 | 19.65 |
| M8 | 723.0 | 718.0 | 579.0 | 700.0 | C10:1-C12:0 or C8:0-C14:2 | 1.56 |
| M9 | 725.1 | 720.1 | 581.1 | 702.1 | C8:1-C14:0 | 6.12 |